ResearcherSun Yat-sen UniversityActive in the last 2 years
Yue Zhao
Matched on ORCID iD 0000-0002-9603-8665; OpenAlex author ID A5101631932. Sources: OpenAlex.
Their work
- Papers
- 8
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 29
2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 2 papers · 2023: none · 2024: 4 papers
Papers 8
- Extracellular vesicle-packaged lncRNA from cancer-associated fibroblasts promotes immune evasion by downregulating HLA-A in pancreatic cancer. Co-author DOI 10.1002/jev2.12484↗
- Tumor-associated macrophages drive glycolysis through the IL-8/STAT3/GLUT3 signaling pathway in pancreatic cancer progression. Co-author DOI 10.1016/j.canlet.2024.216784↗
- Glycolysis and tumor progression promoted by the m6A writer VIRMA via m6A-dependent upregulation of STRA6 in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2024.216840↗
- Low-dose arsenic trioxide inhibits pancreatic stellate cell activation via LOXL3 expression to enhance immunotherapy in pancreatic cancer. Co-author DOI 10.1038/s41416-024-02880-8↗
- Corrigendum to "LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9" [Canc. Lett. 410 (2017) 68-81]. Co-author DOI 10.1016/j.canlet.2022.215836↗
- Arsenic trioxide-loaded nanoparticles enhance the chemosensitivity of gemcitabine in pancreatic cancer via the reversal of pancreatic stellate cell desmoplasia… Co-author DOI 10.1039/d2bm01039a↗
- LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9. Co-author DOI 10.1016/j.canlet.2017.09.019↗
- Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer cells. Co-author DOI 10.1038/cddiscovery.2017.4↗
Closest collaborators
The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kaihong Huang · 5 shared papers, 2022–2024 · strength 0.94
- Paper Glycolysis and tumor progression promoted by the m6A writer VIRMA via m6A-dependent upregulation of STRA6 in pancreatic… DOI 10.1016/j.canlet.2024.216840↗
- Paper Low-dose arsenic trioxide inhibits pancreatic stellate cell activation via LOXL3 expression to enhance immunotherapy in… DOI 10.1038/s41416-024-02880-8↗
- Paper Tumor-associated macrophages drive glycolysis through the IL-8/STAT3/GLUT3 signaling pathway in pancreatic cancer progr… DOI 10.1016/j.canlet.2024.216784↗
- Jinmao Zou · 4 shared papers, 2024 · strength 0.79
- Paper Glycolysis and tumor progression promoted by the m6A writer VIRMA via m6A-dependent upregulation of STRA6 in pancreatic… DOI 10.1016/j.canlet.2024.216840↗
- Paper Low-dose arsenic trioxide inhibits pancreatic stellate cell activation via LOXL3 expression to enhance immunotherapy in… DOI 10.1038/s41416-024-02880-8↗
- Paper Tumor-associated macrophages drive glycolysis through the IL-8/STAT3/GLUT3 signaling pathway in pancreatic cancer progr… DOI 10.1016/j.canlet.2024.216784↗
- Ziyi Zhong · 4 shared papers, 2024 · strength 0.79
- Paper Glycolysis and tumor progression promoted by the m6A writer VIRMA via m6A-dependent upregulation of STRA6 in pancreatic… DOI 10.1016/j.canlet.2024.216840↗
- Paper Low-dose arsenic trioxide inhibits pancreatic stellate cell activation via LOXL3 expression to enhance immunotherapy in… DOI 10.1038/s41416-024-02880-8↗
- Paper Tumor-associated macrophages drive glycolysis through the IL-8/STAT3/GLUT3 signaling pathway in pancreatic cancer progr… DOI 10.1016/j.canlet.2024.216784↗
- Yaqing Li · 4 shared papers, 2022–2024 · strength 0.74
- Paper Glycolysis and tumor progression promoted by the m6A writer VIRMA via m6A-dependent upregulation of STRA6 in pancreatic… DOI 10.1016/j.canlet.2024.216840↗
- Paper Low-dose arsenic trioxide inhibits pancreatic stellate cell activation via LOXL3 expression to enhance immunotherapy in… DOI 10.1038/s41416-024-02880-8↗
- Paper Extracellular vesicle-packaged lncRNA from cancer-associated fibroblasts promotes immune evasion by downregulating HLA-… DOI 10.1002/jev2.12484↗
- Kege Yang · 4 shared papers, 2022–2024 · strength 0.74
- Paper Glycolysis and tumor progression promoted by the m6A writer VIRMA via m6A-dependent upregulation of STRA6 in pancreatic… DOI 10.1016/j.canlet.2024.216840↗
- Paper Tumor-associated macrophages drive glycolysis through the IL-8/STAT3/GLUT3 signaling pathway in pancreatic cancer progr… DOI 10.1016/j.canlet.2024.216784↗
- Paper Extracellular vesicle-packaged lncRNA from cancer-associated fibroblasts promotes immune evasion by downregulating HLA-… DOI 10.1002/jev2.12484↗
- Shurui Zhou · 3 shared papers, 2024 · strength 0.59
- Paper Glycolysis and tumor progression promoted by the m6A writer VIRMA via m6A-dependent upregulation of STRA6 in pancreatic… DOI 10.1016/j.canlet.2024.216840↗
- Paper Tumor-associated macrophages drive glycolysis through the IL-8/STAT3/GLUT3 signaling pathway in pancreatic cancer progr… DOI 10.1016/j.canlet.2024.216784↗
- Paper Extracellular vesicle-packaged lncRNA from cancer-associated fibroblasts promotes immune evasion by downregulating HLA-… DOI 10.1002/jev2.12484↗
- Shaojie Chen · 3 shared papers, 2022–2024 · strength 0.55
- Paper Glycolysis and tumor progression promoted by the m6A writer VIRMA via m6A-dependent upregulation of STRA6 in pancreatic… DOI 10.1016/j.canlet.2024.216840↗
- Paper Low-dose arsenic trioxide inhibits pancreatic stellate cell activation via LOXL3 expression to enhance immunotherapy in… DOI 10.1038/s41416-024-02880-8↗
- Paper Arsenic trioxide-loaded nanoparticles enhance the chemosensitivity of gemcitabine in pancreatic cancer via the reversal… DOI 10.1039/d2bm01039a↗
- Jiajia Li · 3 shared papers, 2022–2024 · strength 0.55
- Paper Low-dose arsenic trioxide inhibits pancreatic stellate cell activation via LOXL3 expression to enhance immunotherapy in… DOI 10.1038/s41416-024-02880-8↗
- Paper Tumor-associated macrophages drive glycolysis through the IL-8/STAT3/GLUT3 signaling pathway in pancreatic cancer progr… DOI 10.1016/j.canlet.2024.216784↗
- Paper Arsenic trioxide-loaded nanoparticles enhance the chemosensitivity of gemcitabine in pancreatic cancer via the reversal… DOI 10.1039/d2bm01039a↗
- Guoda Lian · 3 shared papers, 2022–2024 · strength 0.54
- Paper Low-dose arsenic trioxide inhibits pancreatic stellate cell activation via LOXL3 expression to enhance immunotherapy in… DOI 10.1038/s41416-024-02880-8↗
- Paper Extracellular vesicle-packaged lncRNA from cancer-associated fibroblasts promotes immune evasion by downregulating HLA-… DOI 10.1002/jev2.12484↗
- Paper Arsenic trioxide-loaded nanoparticles enhance the chemosensitivity of gemcitabine in pancreatic cancer via the reversal… DOI 10.1039/d2bm01039a↗
- Hanming Yao · 3 shared papers, 2022–2024 · strength 0.54
- Paper Tumor-associated macrophages drive glycolysis through the IL-8/STAT3/GLUT3 signaling pathway in pancreatic cancer progr… DOI 10.1016/j.canlet.2024.216784↗
- Paper Extracellular vesicle-packaged lncRNA from cancer-associated fibroblasts promotes immune evasion by downregulating HLA-… DOI 10.1002/jev2.12484↗
- Paper Arsenic trioxide-loaded nanoparticles enhance the chemosensitivity of gemcitabine in pancreatic cancer via the reversal… DOI 10.1039/d2bm01039a↗
- Yunlong Li · 2 shared papers, 2024 · strength 0.40
- Paper Low-dose arsenic trioxide inhibits pancreatic stellate cell activation via LOXL3 expression to enhance immunotherapy in… DOI 10.1038/s41416-024-02880-8↗
- Paper Tumor-associated macrophages drive glycolysis through the IL-8/STAT3/GLUT3 signaling pathway in pancreatic cancer progr… DOI 10.1016/j.canlet.2024.216784↗
- Zhiqiang Fu · 3 shared papers, 2017–2022 · strength 0.25
- Paper Corrigendum to "LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9" [Ca… DOI 10.1016/j.canlet.2022.215836↗
- Paper LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9. DOI 10.1016/j.canlet.2017.09.019↗
- Paper Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer … DOI 10.1038/cddiscovery.2017.4↗
- Quanbo Zhou · 3 shared papers, 2017–2022 · strength 0.25
- Paper Corrigendum to "LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9" [Ca… DOI 10.1016/j.canlet.2022.215836↗
- Paper LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9. DOI 10.1016/j.canlet.2017.09.019↗
- Paper Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer … DOI 10.1038/cddiscovery.2017.4↗
- Rufu Chen · 3 shared papers, 2017–2022 · strength 0.25
- Paper Corrigendum to "LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9" [Ca… DOI 10.1016/j.canlet.2022.215836↗
- Paper LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9. DOI 10.1016/j.canlet.2017.09.019↗
- Paper Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer … DOI 10.1038/cddiscovery.2017.4↗
- Xiaohui Zhao · 3 shared papers, 2017–2022 · strength 0.25
- Paper Corrigendum to "LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9" [Ca… DOI 10.1016/j.canlet.2022.215836↗
- Paper LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9. DOI 10.1016/j.canlet.2017.09.019↗
- Paper Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer … DOI 10.1038/cddiscovery.2017.4↗
- Huilin Ye · 3 shared papers, 2017–2022 · strength 0.25
- Paper Corrigendum to "LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9" [Ca… DOI 10.1016/j.canlet.2022.215836↗
- Paper LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9. DOI 10.1016/j.canlet.2017.09.019↗
- Paper Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer … DOI 10.1038/cddiscovery.2017.4↗
- Shangyou Zheng · 3 shared papers, 2017–2022 · strength 0.25
- Paper Corrigendum to "LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9" [Ca… DOI 10.1016/j.canlet.2022.215836↗
- Paper LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9. DOI 10.1016/j.canlet.2017.09.019↗
- Paper Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer … DOI 10.1038/cddiscovery.2017.4↗
- Yuzhou Huang · 1 shared paper, 2024 · strength 0.20
- Shaojie Chen · 1 shared paper, 2024 · strength 0.20
- Yuzhou Huang · 1 shared paper, 2024 · strength 0.20
- Changhao Chen · 2 shared papers, 2017–2022 · strength 0.19
- Paper Corrigendum to "LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9" [Ca… DOI 10.1016/j.canlet.2022.215836↗
- Paper LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9. DOI 10.1016/j.canlet.2017.09.019↗
- Jiajia Li · 1 shared paper, 2024 · strength 0.19
- Shangxiang Chen · 1 shared paper, 2022 · strength 0.15
- Lusheng Wei · 1 shared paper, 2017 · strength 0.06
- Guolin Li · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.